Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Edesa Biotech, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 22 | 26 | +4 |
| Shares | 1.63M | 2.25M | +616.6K (+37.8%) |
| Value | $3.53M | $2.05M | −$1.48M (−41.8%) |
New holders (6)
Institutions that held Edesa Biotech, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 26,708 | $24.4K | 0.00% |
| Renaissance Technologies LLC | 17,502 | $16.0K | 0.00% |
| Sawtooth Solutions, LLC | 10,000 | $9.12K | 0.00% |
| Global Retirement Partners, LLC | 175 | $196 | 0.00% |
| The PNC Financial Services Group, Inc. | 35 | $32 | 0.00% |
| CWM, LLC | 150 | $0 | 0.00% |
Sold out (2)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 15,211 | $32.9K |
| Morgan Stanley | 1,371 | $2.96K |